RENAISSANCE TECHNOLOGIES LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it. Buying this fund's new positions the day each filing went public, over 31 quarters, returned +3.7% per quarter versus +3.1% from owning every 13F stock, beating that baseline in 71.0% of quarters (excess t = 2.56, statistically significant). Caveat: across all 5,072 funds we tested, past performance shows near-zero persistence (rank correlation −0.018) — with thousands of funds, some will look significant by chance alone.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 3213 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| UTHR | $1.1B | | TRIM |
| PLTR | $1.0B | | TRIM |
| AAPL | $781M | | NEW |
| KGC | $780M | | ADD |
| MU | $731M | | TRIM |
| VRSN | $700M | | HOLD |
| EXEL | $589M | | HOLD |
| FNV | $548M | | TRIM |
| SNDK | $508M | | TRIM |
| NVDA | $441M | | ADD |
| CVX | $417M | | TRIM |
| RBLX | $403M | | ADD |
| CVNA | $378M | | TRIM |
| W | $374M | | TRIM |
| HOOD | $354M | | ADD |
| INCY | $344M | | TRIM |
| AGX | $333M | | ADD |
| INTC | $327M | | TRIM |
| NBIX | $319M | | ADD |
| UNH | $313M | | ADD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.